Category | Model | β | P | SE | Model P-value | Model R2 |
---|---|---|---|---|---|---|
Overall | ilr1-MVPA/(SP*SB*LPA) | -0.114 | < 0.05* | 0.049 | < 0.01** | 0.228 |
ilr1-LPA/(MVPA*SP*SB) | -0.382 | < 0.01** | 0.087 | |||
ilr1-SB/(LPA*MVPA*SP) | 0.681 | < 0.01** | 0.083 | |||
ilr1-SP/(SB*MVPA*LPA) | 0.158 | 0.123 | 0.101 | |||
Non-overweight/Non-obese | ilr1-MVPA/(SP*SB*LPA) | -0.064 | 0.173 | 0.047 | < 0.01** | 0.271 |
ilr1-LPA/(MVPA*SP*SB) | -0.177 | < 0.05* | 0.084 | |||
ilr1-SB/(LPA*MVPA*SP) | 0.322 | < 0.01** | 0.079 | |||
ilr1-SP/(SB*MVPA*LPA) | 0.082 | 0.378 | 0.093 | |||
Overweight | ilr1-MVPA/(SP*SB*LPA) | -0.239 | < 0.01* | 0.071 | < 0.01** | 0.443 |
ilr1-LPA/(MVPA*SP*SB) | -0.181 | 0.208 | 0.142 | |||
ilr1-SB/(LPA*MVPA*SP) | 0.612 | < 0.01* | 0.149 | |||
ilr1-SP/(SB*MVPA*LPA) | 0.446 | < 0.05* | 0.191 | |||
Obese | ilr1-MVPA/(SP*SB*LPA) | -0.061 | 0.611 | 0.120 | < 0.01** | 0.519 |
ilr1-LPA/(MVPA*SP*SB) | -0.768 | < 0.01** | 0.185 | |||
ilr1-SB/(LPA*MVPA*SP) | 1.194 | < 0.01** | 0.170 | |||
ilr1-SP/(SB*MVPA*LPA) | 0.408 | 0.100 | 0.244 | |||
Boys | ilr1-MVPA/(SP*SB*LPA) | -0.155 | < 0.05* | 0.077 | < 0.01** | 0.143 |
ilr1-LPA/(MVPA*SP*SB) | -0.394 | < 0.01** | 0.136 | |||
ilr1-SB/(LPA*MVPA*SP) | 0.734 | < 0.01** | 0.122 | |||
ilr1-SP/(SB*MVPA*LPA) | 0.238 | 0.135 | 0.159 | |||
Girls | ilr1-MVPA/(SP*SB*LPA) | -0.057 | 0.33 | 0.059 | < 0.01** | 0.161 |
ilr1-LPA/(MVPA*SP*SB) | -0.398 | < 0.01** | 0.109 | |||
ilr1-SB/(LPA*MVPA*SP) | 0.636 | < 0.01** | 0.109 | |||
ilr1-SP/(SB*MVPA*LPA) | 0.080 | 0.653 | 0.122 |